The introduction of a biosimilar drug into the Irish market will save the Health Service Executive (HSE) millions of euro this year alone. In September Biogen’s Benepali became the first biosimilar approved for the Irish market since the signing of a new drug pricing agreement in July. Its arrival in Ireland meant that Pfizer was … Continue reading Biosimilar Drug to Save HSE Millions of Euro This Year